| |
|
|
|
scPharmaceuticals Inc.  
|
|
5.21 0.06 (0.01%) |
07-19 16:00 |
|
Open: |
5.19 |
Pre close: |
5.15 |
Target:
|
6.76
|
|
High: |
5.46 |
Low: |
5.0801 |
Resistance:
|
5.79
6.76
|
|
Volume: |
77,677 |
Market Cap: |
97M |
Support:
|
3.93
2.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.74
 |
MACD |
MACD(12,26):
|
0.41 |
|
MA(20): |
3.70 |
Signal(12,26,9): |
0.20 |
|
MA(100): |
3.34 |
Stochastic Oscillator |
%K(14,3):
|
83.36  |
|
MA(250): |
4.05 |
%D(3): |
87.95 |
|
Average Volume(K) |
3-Month: |
8495
|
52-Week |
High:
|
6.10 |
|
10-Days: |
7762 |
Low: |
2.44 |
|
RSI |
RSI(14):
|
76.47 |
Change(%): |
8.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.585 |
Return on Equity (ttm) |
-35.0 |
Shares Out. (M) |
18.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.7 |
Shares Float (M) |
3.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
77.16 |
|
Forward EPS |
-2.159 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
828 |
|
Book Value (p.s.) |
3.790 |
EBITDA (p.s.) |
-1.534 |
P/E |
-3.29 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.37 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.86 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.24 |
P/CF |
-3.74 |
|
|
|
|
|
|
